David J. Eyerman, Ph.D.
Affiliations: | 2008 | Boston University, Boston, MA, United States |
Area:
Pharmacology, Neuroscience BiologyGoogle:
"David Eyerman"Mean distance: 19430.2
Parents
Sign in to add mentor| Bryan K. Yamamoto | grad student | 2008 | Boston University | |
| (The role of the vesicular monoamine transporter-2 and nicotinic acetylcholine receptors in methamphetamine toxicity to the rat striatum.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cunningham JI, Todtenkopf MS, Dean RL, et al. (2021) Samidorphan, an opioid receptor antagonist, attenuates drug-induced increases in extracellular dopamine concentrations and drug self-administration in male Wistar rats. Pharmacology, Biochemistry, and Behavior. 173157 |
| Ferdousi MI, Calcagno P, Clarke M, et al. (2020) Hyporesponsivity to mu-opioid receptor agonism in the Wistar-Kyoto rat model of altered nociceptive responding associated with negative affective state. Pain |
| Burke NN, Li Y, Deaver DR, et al. (2019) Chronic administration of buprenorphine in combination with samidorphan produces sustained effects in olfactory bulbectomised rats and Wistar-Kyoto rats. Journal of Psychopharmacology (Oxford, England). 269881119872203 |
| Cunningham JI, Eyerman DJ, Todtenkopf MS, et al. (2019) Samidorphan mitigates olanzapine-induced weight gain and metabolic dysfunction in rats and non-human primates. Journal of Psychopharmacology (Oxford, England). 269881119856850 |
| Cunningham J, Eyerman D, Todtenkopf M, et al. (2019) P.125 Samidorphan, an opioid receptor antagonist, mitigates olanzapine-induced metabolic dysfunction in female rats European Neuropsychopharmacology. 29: S103-S104 |
| Smith K, Deaver D, Dean R, et al. (2019) Mu dependent effects of buprenorphine in combination with samidorphan on immobility behavior in Wistar Kyoto rats European Neuropsychopharmacology. 29: S63-S64 |
| Cunningham J, Eyerman DJ, Todtenkopf M, et al. (2019) F160. Samidorphan, an Opioid Receptor Antagonist, Mitigates Olanzapine-Induced Metabolic Dysfunction in Female Rats Biological Psychiatry. 85: S275 |
| Smith KL, Cunningham JI, Eyerman DJ, et al. (2018) Opioid system modulators buprenorphine and samidorphan alter behavior and extracellular neurotransmitter concentrations in the Wistar Kyoto rat. Neuropharmacology |
| Cunningham J, Smith K, Dean R, et al. (2015) P.2.a.016 The effects of buprenorphine in combination with samidorphan on neurochemical and behavioral measures in Wistar Kyoto rats European Neuropsychopharmacology. 25: S384 |
| Cunningham J, Dean R, Todtenkopf M, et al. (2014) P.3.a.009 Samidorphan attenuates drug-induced increases in extracellular dopamine concentrations and drug self-administration in rats European Neuropsychopharmacology. 24: S489 |